Nexus Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.2M Sell
66,292
-680
-1% -$326K 4.33% 9
2026
Q1
$32.9M Sell
66,972
-325
-0.5% -$176K 4.6% 10
2025
Q4
$39M Sell
67,297
-240
-0.4% -$136K 5.31% 8
2025
Q3
$32.8M Buy
67,537
+7,510
+13% +$3.5M 4.65% 9
2025
Q2
$24.3M Buy
+60,027
New +$25.1M 3.64% 13

Other funds holding TMO

Nexus Investment Management's TMO Position: Q2 2026 in Review

Nexus Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, selling an estimated $326K and leaving 66,292 shares worth $33.2M. The position accounts for 4.33% of the portfolio, ranked #9.

Nexus Investment Management first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $39M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nexus Investment Management held 66,292 shares of Thermo Fisher Scientific worth $33.2M as of Q2 2026.
  • Nexus Investment Management sold 680 Thermo Fisher Scientific shares in Q2 2026, an estimated $326K.
  • Thermo Fisher Scientific made up 4.33% of Nexus Investment Management's portfolio in Q2 2026, its #9 holding.
  • Nexus Investment Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Nexus Investment Management's Thermo Fisher Scientific position peaked at $39M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.